Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America

Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article...

Descripción completa

Detalles Bibliográficos
Autores: Condino Neto, A., Costa Carvalho, B. T., Grumach, A. S., King, A., Bezrodnik, Liliana, Oleastro, M., Leiva, L., Porras, O., Espinosa Rosales, F. J., Franco, J. L., Sorensen, R. U.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/197433
Acceso en línea:http://hdl.handle.net/11336/197433
Access Level:acceso abierto
Palabra clave:GUIDELINES
IMMUNOGLOBULIN REPLACEMENT THERAPY
INTRAVENOUS IMMUNOGLOBULIN
LATIN AMERICA
PRIMARY IMMUNODEFICIENCY
SUBCUTANEOUS IMMUNOGLOBULIN
https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
Descripción
Sumario:Antibodies are an essential component of the adaptative immune response and hold long-term memory of the immunological experiences throughout life. Antibody defects represent approximately half of the well-known primary immunodeficiencies requiring immunoglobulin replacement therapy. In this article, the authors review the current indications and therapeutic protocols in the Latin American environment. Immunoglobulin replacement therapy has been a safe procedure that induces dramatic positive changes in the clinical outcome of patients who carry antibody defects.

Similares en LA Referencia